Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MICB divergent transcript (MICB-DT) is a long non-coding RNA expressed from the MICB gene locus on chromosome 6p21.33, annotated as a non-protein-coding transcript and thought to be primarily involved in transcriptional regulation, possibly through antisense and chromatin-associated mechanisms. It is not known as a therapeutic or diagnostic target, and its direct biological function and disease roles remain largely uncharacterized, though non-coding divergent transcripts at gene promoters broadly play roles in transcriptional regulation and developmental processes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MICB divergent transcript (MICB-DT).